Fundraising Fox
Fraser Murray
InvestorHead of Scientific Evaluation at Advent Life Sciences
Find your path to Fraser
33 people in our graph can introduce you to Fraser.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Shahzad Malik to introduce you to Fraser
You →Shahzad · together at Advent Life Sciences →Fraser
Ask Jamie Chen to introduce you to Fraser
You →Jamie · 11 people · together at Advent Life Sciences →Fraser
Sign up to find every way you can get introduced to Fraser
- Your email: the people you already email who know Fraser
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Fraser
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Fraser Murray is a drug discovery specialist and entrepreneur with nearly 30 years of experience in early drug development across pharma and biotech. In addition to serving as Head of Scientific Evaluation at Advent Life Sciences, he is CEO of portfolio company Pheno Therapeutics, and previously led Pandeia Therapeutics (acquired in December 2022), Chronos Therapeutics, and Polleo Pharma. He began his career at Merck's Neuroscience Research Centre and held roles at AstraZeneca and Shire; he studied Immunology and Pharmacology at the University of Strathclyde, earned a PhD in Neuropharmacology at the University of London, and completed an executive MBA at Alliance Manchester Business School.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
Per the firm's website.
Colleagues at Advent Life Sciences
Frequently asked questions
- Who is Fraser Murray?
- Fraser Murray is a drug discovery specialist and entrepreneur with nearly 30 years of experience in early drug development across pharma and biotech. In addition to serving as Head of Scientific Evaluation at Advent Life Sciences, he is CEO of portfolio company Pheno Therapeutics, and previously led Pandeia Therapeutics (acquired in December 2022), Chronos Therapeutics, and Polleo Pharma. He began his career at Merck's Neuroscience Research Centre and held roles at AstraZeneca and Shire; he studied Immunology and Pharmacology at the University of Strathclyde, earned a PhD in Neuropharmacology at the University of London, and completed an executive MBA at Alliance Manchester Business School.
- Where does Fraser Murray work?
- Fraser Murray is Head of Scientific Evaluation at Advent Life Sciences.
- What does Fraser Murray invest in?
- Fraser Murray invests in Biotech.
- What companies has Fraser Murray invested in?
- Investments tracked here include Pheno Therapeutics.